Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Both are available in Canada as research materials sold under Research Use Only, Not for Human Consumption terms
Whatever you do for weight loss, you have to do it forever, said Roslin
According to the SmPC and STEP clinical trials, these include: Nausea (affecting approximately 40-45% of patients) Vomiting (approximately 15-25% of patients) Diarrhoea (affecting approximately 25-30% of users) Constipation (approximately 20-25% of patients) Abdominal pain and bloating Gastro-oesophageal reflux For individuals taking oral anti-epileptic medications , severe or persistent vomiting could theoretically reduce drug absorption, potentially affecting seizure control
These signs may indicate contamination, degradation, or manufacturing defects that make the medication unsafe for use
